Every Health Matters article, newest first. Use the search or browse by month to find older reporting.
9 September 2026
Portugal's FHC is entering South Africa's sterile injectables market, planning to build a local plant to challenge established players.
9 September 2026
Aspen has abandoned local lenacapavir production, citing no guaranteed demand, and is backing Merck's alimatravir pill instead.
9 September 2026
Discovery Group results for 2026 show profit up 17% to R17.75bn, driven by Discovery Health, the Bank's turnaround and global Vitality growth.
8 September 2026
Mandatory medical scheme membership for taxpayers could cut cover costs by up to 30%, HFA research finds, alongside a risk equalisation fund.
8 September 2026
The 2025 Mediscor Medicines Review shows medicine spend up 4.7%, with generics, chronic care and speciality drugs shaping affordability.
8 September 2026
Aspen Pharmacare earnings rose 22% as demand for Eli Lilly's weight-loss drug Mounjaro surged, with the group also eyeing generic semaglutide.
8 September 2026
The government will bring traditional health practitioners into the NHI as regulation and benefit-sharing take shape.
3 September 2026
Lenacapavir HIV prevention could accelerate South Africa’s epidemic control, but severe supply constraints are limiting the rollout.
3 September 2026
New research on statins and dementia links earlier treatment to a 15% lower dementia risk in people with type 2 diabetes.
29 August 2026
Young adult mental health claims have risen 80% in a decade, Discovery Health data shows, as earlier care-seeking reshapes demand.
28 August 2026
The Dis-Chem succession is pivotal as founder Ivan Saltzman resigns from formal roles. Learn about the changes happening now.
28 August 2026
Ectopic pregnancy deaths remain preventable in South Africa as delayed diagnosis and treatment expose gaps in district care.